Cradle

Engineer better proteins, faster.

Founded 2021

The Netherlands 136 employees Series B Total: $102.50M AI, Biotechnology +1

General Information

Company Name Cradle

Founded Year 2021

Location

The Netherlands

Founders / Decision Makers

Employees 136

Industries AI, Biotechnology, Pharmaceutical

Funding Stage Series B

Business Model SaaS, B2B, Platform

Revenue Model Subscription, Licensing, Usage Based

Offices as of Oct 2026

Amsterdam, The Netherlands Zurich, Switzerland

Social

BounceWatch is an independent company data service, not affiliated with Cradle. To contact Cradle, visit cradle.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cradle compare?

A PDF of Cradle and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cradle soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Award Received Oct 19, 2026

Cradle was recognized as one of 13 AI drug discovery companies worth keeping an eye on in an article by Willow Shah-Neville, highlighting its standing in the AI drug discovery sector.

LinkedIn Growth Oct 19, 2026

LinkedIn followers decreased by 15% over 26 days (32,579 → 27,817).

Growth Metrics Oct 13, 2026

During an internal protein design competition, 100 Cradlers participated in engineering protein variants using their platform.

Feature Release Oct 13, 2026

Cradle has launched EvoFlows, an edit-based flow matching model that determines what and where to edit, including substitutions, insertions, or deletions.

Event Participation Oct 12, 2026

Cradle's Franziska will be speaking about their latest developments at the Festival of Biologics in Basel, Switzerland.

Actively Hiring Oct 05, 2026

Hiring for 5 positions in the last 30 days.

Get alerts when Cradle shows new signals

AI Insight

Bounce Watch AI

2 months ago

Cradle is undergoing significant post-Series B growth and strategic development, marked by aggressive hiring for 68 positions and the expansion of its lab facilities to boost R&D capacity. Further solidifying its market position, the company has joined the Atlas Consortium alongside key industry players, including GSK, to collaboratively address critical data bottlenecks in AI protein engineering. This concerted effort underscores a dual focus on internal scaling and external strategic partnerships to drive innovation and leadership in the biopharmaceutical sector.

Signal Types

Hiring Expansion Partnership

Strategic Labels

Team Growth R&D Scaling Industry Collaboration

Next Move: Scaling

Impact: 8/10

Ideal For: Growth-stage Biotech Investors – Series B/C

About Cradle

Cradle, founded in 2021, is gaining traction in the intersection of AI, Biotechnology, and Pharmaceutical industries. Based in The Netherlands, the company promises to "Engineer better proteins, faster." By leveraging AI technology, Cradle aims to generate protein candidates and enhance their properties, thus achieving breakthroughs with fewer experiments guided by personalized experimental data.

With a notable Series B investment of $73.00M closed on 01 November 2024, Cradle has secured financial backing from prominent investors such as Kindred Capital, Index Ventures, and IVP. These investments underline the confidence of leading venture firms in Cradle's innovative application of AI to protein engineering.

The company is poised for growth as it continues to disrupt traditional processes of protein development, positioning itself as a key player in its industry spaces.

Business keywords: biotech company, protein design, AI design recommendations, intellectual property ownership, machine learning platform, therapeutics development, bio-based products, enzymes, antibodies, pharmaceutical applications, industrial applications, protein engineering, protein activity optimization, protein stability enhancement, protein solubility improvement

Services & Products

Protein Engineering Optimization

AI-Driven Experimental Design

Custom Model Evaluation and Integration

Target Customers

Biopharmaceutical Companies Industrial Biotechnology Researchers R&D Teams in Biotech Therapeutics Developers

Funding Rounds & Investors (3)

View All

Funding Stage	Amount	Investors	Lead Investors	Date
Series B	$73.00M	3	Kindred Capital, Index Ventures +1	01 Nov 2024
Series A	$24.00M	1	Index Ventures	01 Nov 2023
Seed	€5.50M	10	Kindred Capital, Index Ventures +8	01 Nov 2022

Latest News

View All

Turn headwinds into opportunity in 2024

Techcrunch Nov 23, 2025

How EQT uses AI to see the startup world differently

Tech Nov 20, 2025

LEVEL UP 2025 celebrates bold and life-changing entrepreneurship

Tue.nl Sep 30, 2025

‘Europe is not the US’: Tech insiders call for smarter AI rules

Thenextweb Jul 02, 2025

Europe’s AI push: €150 billion pledge to supercharge European AI startups

Eu-startups Feb 10, 2025

Amsterdam deep tech startups that raised €1M & more in 2024

Siliconcanals.com Dec 23, 2024

Cradle Alternatives & Competitors

View All Alternatives

Cradle vs

Profluent United States

Grounded in nature, authored by AI

Venture round

69 employees

AI, Biotechnology

Compare Cradle vs Profluent

Cradle vs

Scala Biodesign Israel

One-shot protein design software.

Seed

28 employees

AI, Biotechnology

Compare Cradle vs Scala Biodesign

Cradle vs

MoleculeMind China

AI-Driven Protein Discovery and Design

Series A

23 employees

Biotechnology, Pharmaceutical

View all alternatives

FAQ About Cradle

Engineer better proteins, faster.

Cradle was founded in 2021.

Cradle is headquartered in The Netherlands. As of Oct 2026, it also has offices in Amsterdam, The Netherlands and Zurich, Switzerland.

Cradle operates in AI, Biotechnology and Pharmaceutical. Its work centres on biotech company, protein design, AI design recommendations and intellectual property ownership. Its customers include Biopharmaceutical Companies, Industrial Biotechnology Researchers and R&D Teams in Biotech.

Cradle has a SaaS, B2B and Platform business model. Its revenue comes from Subscription, Licensing and Usage Based.

Cradle has approximately 136 employees.

Cradle has completed 3 funding rounds, raising a total of $102.50M. The latest funding stage is Series B.

Cradle offers: Protein Engineering Optimization, AI-Driven Experimental Design, Custom Model Evaluation and Integration.

Top alternatives and competitors to Cradle include Profluent, Scala Biodesign, MoleculeMind, Arzeda, BigHat Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Cradle and Profluent are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cradle, https://bouncewatch.com/company/cradle, updated 12 October 2026. When citing, please name BounceWatch and link this page.

Cradle

General Information

Discover More

What changed at Cradle recently?

AI Insight

About Cradle

Services & Products

Target Customers

Funding Rounds & Investors (3)

Latest News

Cradle Alternatives & Competitors

FAQ About Cradle